Genomic epidemiology of group B streptococci spanning 10 years in an Irish maternity hospital, 2008-2017.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
07 2021
Historique:
received: 07 02 2021
revised: 30 03 2021
accepted: 05 04 2021
pubmed: 17 4 2021
medline: 6 8 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

The genomic epidemiology of group b streptococcal (GBS) isolates from the Rotunda maternity hospital, Dublin, 2008-2017, was investigated. Whole genome sequences of isolates (invasive, n = 114; non-invasive, n = 76) from infants and women were analysed using the PubMLST database (https://pubmlst.org/sagalactiae/). Serotypes III (36%), Ia (18%), V (17%), II (11%) and Ib, (9%) and sequence types (ST) 17 (23%), ST-23 (14%), ST-1 (12%) and ST-19 (7%) were most common. Core genome MLST (cgMLST) differentiated isolates of the same ST, grouped STs into five lineages congruent with known clonal complexes and identified known mother-baby pairs and suspected linked infant cases. Clonal complex (CC) 17 accounted for 40% and 22% of infant and maternal invasive cases, respectively and 21% of non-invasive isolates. CC23 and CC19 were associated with maternal disease (30%) and carriage (24%), respectively. Erythromycin (26%) and clindamycin (18%) resistance increased over the study period and was associated with presence of the erm(B) gene (55%), CC1 (33%) and CC19 (24%). A multi-resistant integrative conjugative element incorporated in the PI-1 locus was detected in CC17, an ST-12 and ST-23 isolate confirming the global dissemination of this element. All isolates possessed one or more pilus islands. Genes encoding other potential protective proteins including Sip, C5a peptidase and Srr1 were present in 100%, 99.5% and 65.8% of isolates, respectively. The srr2 gene was unique to CC17. The PubMLST.org website provides a valuable framework for genomic GBS surveillance to inform on local and global GBS epidemiology, preventive and control measures.

Identifiants

pubmed: 33862060
pii: S0163-4453(21)00166-3
doi: 10.1016/j.jinf.2021.04.003
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-45

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest KAJ reports grants from the Wellcome Trust during the conduct of this work and personal fees from GlaxoSmithKline outside of the submitted work. All other authors report no conflict of interest.

Auteurs

Mary Meehan (M)

Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland. Electronic address: mary.meehan@cuh.ie.

Maeve Eogan (M)

Department of Obstetrics and Gynaecology, Rotunda Hospital, Dublin, Ireland.

Naomi McCallion (N)

Department of Neonatology, The Rotunda Hospital, Dublin, Ireland; Department of Paediatrics, The Royal College of Surgeons in Ireland, Dublin, Ireland.

Robert Cunney (R)

Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin, Ireland.

James E Bray (JE)

Department of Zoology, University of Oxford, Peter Medawar Building, Oxford OX1 3SY, UK.

Keith A Jolley (KA)

Department of Zoology, University of Oxford, Peter Medawar Building, Oxford OX1 3SY, UK.

Anastasia Unitt (A)

Department of Zoology, University of Oxford, Peter Medawar Building, Oxford OX1 3SY, UK.

Martin C J Maiden (MCJ)

Department of Zoology, University of Oxford, Peter Medawar Building, Oxford OX1 3SY, UK.

Odile B Harrison (OB)

Department of Zoology, University of Oxford, Peter Medawar Building, Oxford OX1 3SY, UK.

Richard J Drew (RJ)

Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Clinical Innovation Unit, Rotunda Hospital, Dublin, Ireland; Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH